2nd European Lung Cancer Conference

Geneva—Giving lung cancer patients radiotherapy more frequently and over a shorter period of time provides an overall survival benefit, according to the results of a meta-analysis presented at the 2nd European Lung Cancer Conference.

Geneva—Combining high-dose pemetrexed (Alimta, Eli Lilly) with concurrent radiation for lung cancer is feasible, according to results of a phase 1 study presented at the 2nd European Lung Cancer Conference. Administering pemetrexed at high doses with radiation may increase the effectiveness of treatment.